KPV Dosage: What the Evidence Says (2026)
Not FDA-approved
Three-amino-acid fragment of alpha-MSH studied in animal colitis models. No human dosing data.
Also called: Lys-Pro-Val, alpha-MSH(11-13)
Regulatory status (US)
Not approved by the FDA for any use. FDA removed it from its "significant safety risk" compounding list in April 2026 after the nomination was withdrawn, and an FDA advisory committee voted in favor of allowing pharmacy compounding in July 2026, against the recommendation of FDA staff. On October 30, 2026, HHS published a draft policy saying it does not intend to take enforcement action against state-licensed pharmacies that compound it for a named patient with a prescription, under listed conditions and routes. That is not an FDA approval and says nothing about safety or effectiveness. The draft policy names topical and oral use only, not injection.
What it is
The last three amino acids of alpha-MSH, studied for anti-inflammatory effects in animal models of colitis.
Dosage
KPV reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- No human dosing data (FDA: no human exposure data).
Safety
- No established human dose.
Questions
- Is KPV FDA-approved?
- Not approved by the FDA for any use. FDA removed it from its "significant safety risk" compounding list in April 2026 after the nomination was withdrawn, and an FDA advisory committee voted in favor of allowing pharmacy compounding in July 2026, against the recommendation of FDA staff. On October 30, 2026, HHS published a draft policy saying it does not intend to take enforcement action against state-licensed pharmacies that compound it for a named patient with a prescription, under listed conditions and routes. That is not an FDA approval and says nothing about safety or effectiveness. The draft policy names topical and oral use only, not injection.
- What dose of KPV has been studied?
- There is no established human dose. No human dosing data (FDA: no human exposure data).
- How many units is my KPV dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Sources
- FDA: Certain bulk drug substances for compounding that may present significant safety risks
- Federal Register (public inspection) 2026-07361: peptide category changes
- PharmExec: FDA advisory committee votes to loosen restrictions on peptides (Jul 2026)
- Federal Register 2026-22192: HHS draft enforcement discretion policy for 503A compounding of certain peptides (Oct 30, 2026)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.